Dr. Laura

Biography Dr. Laura Andreoli


Laura Andreoli specialized in Rheumatology in 2010 and obtained her PhD degree in “Methodology of Clinical Research” in 2015 at the University of Brescia (Italy).

She was appointed as Assistant Professor in Rheumatology (2014-2019) and Associate Professor in Rheumatology (2019-ongoing) at the University of Brescia.

She’s been working as Consultant Physician at the Rheumatology and Clinical Immunology Unit of Spedali Civili in Brescia since 2013.

Since May 2024, she is Visiting Professor at Centre for Expertise in Rheumatology (CeViG) at the Danish Hospital for Rheumatic Diseases (Dansk Gigthospital) in Sønderborg, Denmark. 

Her main interests include the pathogenesis, diagnosis and treatment of systemic autoimmune diseases, particularly systemic lupus erythematosus and the antiphospholipid syndrome, and their related autoantibodies. The research activity has been conducted within the frame of national/international networks.

Since 2006, she’s been working in the Pregnancy Clinic in Brescia (joined team of rheumatologists, gynecologists, neonatologists), which is dedicated to the management of pregnancy in patients with inflammatory arthritis and systemic autoimmune diseases. Research activity focused on the predictors of adverse pregnancy outcomes and on the implications of the use of anti-rheumatic drugs (conventional and biologic) in pregnant patients.


She served as fellow in charge of the literature review for the “2017 EULAR Recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome” (Ann Rheum Dis. 2017;76(3):476-485) and for the “2019 EULAR Recommendations for the management of antiphospholipid syndrome in adults” (Ann Rheum Dis. 2019;78(10):1296-1304; RMD Open 2019;5(1):e000924).

Since 2018 she’s been co-PI (together with Prof. Angela Tincani) of the “Italian Registry of Pregnancy in Rheumatic Diseases” (P-RHEUM.it Study) supported by the Italian Society for Rheumatology.

She is co-leading the EULAR study group on Reproductive Healthcare and Family Planning (ReHFaP study group) alongside Prof Karen Schreiber from Denmark.

She is author/coauthor of nearly 210 publications on international journals indexed by PubMed.